Jenna Sopfe

Dr. Jenna Sopfe


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Critical Care Medicine
Verified
Journal Article
Closed access
HSHeidi A. B. Md Smith
Heidi A. B. Md Smith
JBJenny Boyd
Jenny Boyd
DFD. Catherine Fuchs
D. Catherine Fuchs
KMKelly Melvin
Kelly Melvin
PBPamela Berry
Pamela Berry
EEE. Wesley Ely
E. Wesley Ely
Objective: To validate a diagnostic instrument for pediatric delirium in critically ill children, both ventilated and nonventilated, that uses standardized, developmentally appropriate measurements. Design and Setting: A prospective observational cohort study investigating the Pediatric Confusion Assessment Method for Intensive Care Unit (pCAM-ICU) patients in the pediatric medical, surgical, and cardiac intensive care unit of a university-based medical center. Patients: A total of 68 pediatric critically ill patients, at least 5 years of age, were enrolled from July 1, 2008, to March 30, 2009. Interventions: None. Measurements: Criterion validity including sensitivity and specificity and interrater reliability were determined using daily delirium assessments with the pCAM-ICU by two critical care clinicians compared with delirium diagnosis by pediatric psychiatrists using Diagnostic and Statistical Manual, 4th Edition, Text Revision criteria. Results: A total of 146 paired assessments were completed among 68 enrolled patients with a mean age of 12.2 yrs. Compared with the reference standard for diagnosing delirium, the pCAM-ICU demonstrated a sensitivity of 83% (95% confidence interval, 66–93%), a specificity of 99% (95% confidence interval, 95–100%), and a high interrater reliability (κ = 0.96; 95% confidence interval, 0.74–1.0). Conclusions: The pCAM-ICU is a highly valid reliable instrument for the diagnosis of pediatric delirium in critically ill children chronologically and developmentally at least 5 yrs of age. Use of the pCAM-ICU may expedite diagnosis and consultation with neuropsychiatry specialists for treatment of pediatric delirium. In addition, the pCAM-ICU may provide a means for delirium monitoring in future epidemiologic and interventional studies in critically ill children.

24 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JSJenna Sopfe
Jenna Sopfe
JPJessica Pettigrew
Jessica Pettigrew
AAAnosheh Afghahi
Anosheh Afghahi
LALeslie C. Appiah
Leslie C. Appiah
HCHelen L. Coons
Helen L. Coons
Sexual health concerns, both physical and psychological, are common and represent an unmet need among women with and surviving cancer. Sexual challenges and conditions negatively impact body image, satisfaction, relationships, well-being, and quality of life, yet are widely reported to be under-recognized and undertreated. To guide clinical care and future research on sexual function in women with cancer, we performed a scoping review of interventions for sexual health concerns, including sexual function, body image, genitourinary symptoms, and hot flashes. Relevant publications between 2005 and 2020 were identified by searching PubMed with a combination of medical subject headings and keywords. Articles were included if they focused on the aforementioned topics, were primary research publications, and included female cancer survivors. Studies focusing on women receiving hormone therapy for breast cancer were also included. A total of 91 investigations conducted in the US and abroad were reviewed. Most commonly, interventions included a component of psychoeducation, although pharmacologic, exercise, and other approaches have been evaluated. Many studies have focused on survivors of breast or gynecologic cancer, among other sampling and methodological limitations. These limitations underscore the need for more work on this vital survivorship issue. Recommendations for future research in this area are also offered.

1 October 2020 in Journal of Adolescent and Young Adult Oncology
Verified
Journal Article
Closed access
JSJenna Sopfe
Jenna Sopfe
AGAbha Gupta
Abha Gupta
LALeslie C. Appiah
Leslie C. Appiah
ECEric J. Chow
Eric J. Chow
PPPamela N. Peterson
Pamela N. Peterson
An area of concern affecting the quality of life of childhood cancer survivors (CCS) is that of sexual dysfunction (SD), which may be a result of both physical and psychosexual challenges associated with cancer and its treatment. This is especially pertinent as CCS are known to experience diminished quality of life compared to peers. Relevant to SD, cancer and its associated treatment are associated with negative effects on body image and romantic relationships, as well as overall physical and mental health. Although CCS have been shown to have SD at higher rates than the general population, this is often under-recognized and CCS commonly report that it is not addressed by their health care providers. To guide future research and improve clinical screening and treatment practices for SD, we performed a narrative review of this understudied topic to summarize existing knowledge of the incidence, risk factors, pathophysiology, and rates of screening for SD in CCS. We also outline current gaps in knowledge and directions for future research.

24 January 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
JSJenna Sopfe
Jenna Sopfe
AEAshley Endres
Ashley Endres
KCKristen Campbell
Kristen Campbell
KHKari Hayes
Kari Hayes
ATAndrew T. Trout
Andrew T. Trout
CCCarrye R. Cost
Carrye R. Cost
Background: Castleman disease (CD) is an uncommon lymphoproliferative disorder that is rare in pediatric populations; the literature describing this population is sparse. We sought to describe pediatric CD, including unicentric CD (UCD) and human herpes virus‐8 (HHV8)‐negative multicentric CD (MCD), in a multi‐institutional cohort.Methods: We retrospectively reviewed 24 patients, aged 0 to 26 years at diagnosis, who were diagnosed with CD between January 1, 2005, and May 16, 2017, at two tertiary children's hospitals. Demographic and clinical data were collected.Results: Most patients (75%, 18/24) presented with UCD. All patients with MCD were HHV8‐negative. The most common histopathologic variant was hyaline vascular (75%, 18/24). Plasma cell variant occurred in 33% (2/6 [95% confidence intervals (CI), 4–78%]) of patients with HHV8‐negative MCD and 17% (3/18 [95% CI, 4–41%]) of patients with UCD. Systemic symptoms were present in 4 of 6 of patients with HHV8‐negative MCD and 8 of 18 of patients with UCD. Anemia and laboratory inflammation occurred in both UCD and MCD patients, with nonsignificantly higher rates of anemia and elevated C‐reactive protein in MCD patients. All but two UCD patients underwent gross total resection as definitive therapy. Among HHV8‐negative MCD patients, a combination of resection, chemotherapy, and immunotherapy was used. No UCD patients and three of six HHV8‐negative MCD patients experienced disease progression/relapse prior to lasting remission. There were no deaths.Conclusion: Pediatric patients with CD most commonly have unicentric, hyaline vascular variant disease. Pediatric patients with both UCD and MCD commonly have systemic inflammation and, despite risk of progression/relapse in MCD patients, ultimately have excellent survival.

17 June 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
CPCharles A. Phillips
Charles A. Phillips
HRHanieh Razzaghi
Hanieh Razzaghi
TATaylor Aglio
Taylor Aglio
MMMichael McNeil
Michael McNeil
MSMikaela Salvesen‐Quinn
Mikaela Salvesen‐Quinn
LBL. Charles Bailey
L. Charles Bailey

1 May 2017 in Academic Pediatrics
Verified
Journal Article
Closed access
LZLaura Zastoupil
Laura Zastoupil
AMAmanda McIntosh
Amanda McIntosh
JSJenna Sopfe
Jenna Sopfe
JBJason Burrows
Jason Burrows
JKJessica Kraynik
Jessica Kraynik
LSL. Barry Seltz
L. Barry Seltz